Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5921 Riley Park Dr
Fort Smith, AR 72916Phone+1 479-420-1221Fax+1 479-646-0133
Education & Training
- University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 1996 - 1997
- Northeast Ohio Medical UniversityClass of 1996
- Northeastern Ohio Universities College of MedicineClass of 1996
Certifications & Licensure
- AR State Medical License 1997 - 2025
- OK State Medical License 2024 - 2025
- OH State Medical License 2004 - 2006
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2018 Feb 20
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
- Candin for the Treatment of Common Warts Start of enrollment: 2024 Mar 05
Roles: Contact
Publications & Presentations
PubMed
- Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.Joel M Gelfand, April W Armstrong, Henry W Lim, Steven R Feldman, Sandra M Johnson
JAMA Dermatology. 2024-12-01 - Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.McKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, Misha Haq, Victoria Shi
JAMA Dermatology. 2024-06-01 - Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson
Dermatology and Therapy. 2024-02-01
Books/Book Chapters
Press Mentions
- Rosacea Commonly UnderdiagnosedFebruary 12th, 2020
- FDA Approves AkliefDecember 9th, 2019
- FDA Approves New Topical Cream to Treat AcneOctober 4th, 2019
- Join now to see all
Grant Support
- Immunotherapy And Science Of Warts Using Intralesional Skin Test AntigensNational Center For Research Resources2005
- Immunotherapy Of Warts--Intralesional Skin Test AntigensNational Center For Research Resources2004
- Immunotherapy Of WartsNational Center For Research Resources2004
Professional Memberships
- Fellow
- Fellow
External Links
- Johnson Dermatologyhttp://Www.johnsondermatology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: